ENTITY

Medgenics Inc (MDGN US)

Analysis

Health Care • United States

Aevi Genomic Medicine, Inc. operates as a biotechnology company. The Company focuses on translating genetic discoveries into novel therapies to improve the lives of children and adults. Aevi Genomic Medicine offers its services in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00